Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 18;15(6):971.
doi: 10.3390/life15060971.

The Platelet-to-Lymphocyte Ratio (PLR) as a Non-Invasive Biomarker for Cervical Malignancy in Conization Patients

Affiliations

The Platelet-to-Lymphocyte Ratio (PLR) as a Non-Invasive Biomarker for Cervical Malignancy in Conization Patients

Noémi Kalas et al. Life (Basel). .

Abstract

Background: Cervical cancer continues to pose a significant global health challenge, particularly in low-resource regions with limited access to advanced diagnostics. Cervical conization can occasionally uncover invasive carcinoma in patients initially suspected of having only pre-invasive lesions. This study assessed the platelet-to-lymphocyte ratio (PLR) as a potential predictive biomarker for identifying invasive disease in patients undergoing a loop electrosurgical excision procedure (LEEP).

Methods: A retrospective study was conducted on 371 patients who underwent LEEP conization for cervical dysplasia. Preoperative PLR values were collected and compared across final histopathological categories (negative, low-grade, high-grade, invasive carcinoma) using the Kruskal-Wallis test, followed by Mann-Whitney U tests for pairwise comparisons. Receiver operating characteristic (ROC) analysis was used to evaluate diagnostic accuracy.

Results: PLR values above 7.7 were significantly associated with HPV positivity, increasing with histopathological severity. There were significant PLR differences across the outcome groups (p = 0.005), with notably higher values in cases of invasive carcinoma (p < 0.01). ROC analysis showed moderate diagnostic utility (AUC ≈ 0.72); at a PLR cutoff of ~11.9, sensitivity was 65% and specificity 81%.

Conclusions: The PLR cutoff of 7.7 was associated with HPV positivity, while a higher cutoff of 11.93 was identified for predicting invasive cervical cancer. These findings support that preoperative PLR is a non-invasive, clinically relevant marker correlated with lesion severity, offering potential for preoperative risk stratification, particularly where advanced diagnostics are limited.

Keywords: HPV DNA; ROC analysis; biomarkers; cervical cancer; invasive carcinoma; platelet-to-lymphocyte ratio (PLR); risk stratification; systemic inflammation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Flowchart of patient selection for the SCOPE Study.
Figure 2
Figure 2
Boxplot of PLR values by HPV DNA status. Boxplot compares the distribution of PLR values between HPV DNA-negative and HPV DNA-positive patients. The median PLR was higher in HPV-positive individuals, with a wider range of values. Asterisks (*) denote a statistically significant difference between the two groups (p < 0.05).
Figure 3
Figure 3
Boxplot of PLR values across histological grades. This figure illustrates the distribution of PLR values across four histopathological conization grades: Grade I (negative), Grade II (low-grade lesions), Grade III (high-grade lesions), and Grade IV (invasive carcinoma). The plot reveals a progressive increase in PLR with advancing disease severity, with Grade IV showing significantly higher PLR values compared to Grades I, II, and III. Asterisks (*) denote statistically significant differences between the groups.
Figure 4
Figure 4
Distribution of histological grades within quartile-based PLR groups. This stacked bar chart shows the percentage of conization outcomes (Grades I–IV) within four quartile ranges (Q1: 3.3–6.9; Q2: 7.0–8.9; Q3: 8.9–11.3; Q4: 11.3–184.2) of the platelet-to-lymphocyte ratio (PLR). As PLR values increase, the proportion of patients with invasive carcinoma (Grade IV, red) also increases, whereas the proportion of benign (Grade I, green) or low-grade lesions (Grade II, light green) decreases.
Figure 5
Figure 5
Receiver operating characteristic (ROC) curve for PLR in predicting cervical cancer. ROC curve compares the diagnostic performance of the platelet-to-lymphocyte ratio for identifying cervical cancer. Sensitivity (true-positive rate) is plotted on the y-axis, while 1-specificity (false-positive rate) is on the x-axis.

Similar articles

References

    1. Vu M., Yu J., Awolude O.A., Chuang L. Cervical cancer worldwide. Curr. Probl. Cancer. 2018;42:457–465. doi: 10.1016/j.currproblcancer.2018.06.003. - DOI - PubMed
    1. Kusakabe M., Taguchi A., Sone K., Mori M., Osuga Y. Carcinogenesis and management of human papillomavirus-associated cervical cancer. Int. J. Clin. Oncol. 2023;28:965–974. doi: 10.1007/s10147-023-02337-7. - DOI - PMC - PubMed
    1. Bobdey S., Sathwara J., Jain A., Balasubramaniam G. Burden of cervical cancer and role of screening in India. Indian J. Med. Paediatr. Oncol. 2016;37:278–285. doi: 10.4103/0971-5851.195751. - DOI - PMC - PubMed
    1. Mathivanan S.K., Francis D., Srinivasan S., Khatavkar V., P K., Shah M.A. Enhancing cervical cancer detection and robust classification through a fusion of deep learning models. Sci. Rep. 2024;14:10812. doi: 10.1038/s41598-024-61063-w. - DOI - PMC - PubMed
    1. Bedell S.L., Goldstein L.S., Goldstein A.R., Goldstein A.T. Cervical Cancer Screening: Past, Present, and Future. Sex. Med. Rev. 2020;8:28–37. doi: 10.1016/j.sxmr.2019.09.005. - DOI - PubMed

LinkOut - more resources